Something Evil This Way Comes: Direct to Consumer With a Deadly Flavor
The Natural Solutions Foundation, the leading Global Health Freedom organization, is proud to present this information to you. We protect your right to know about – and to use – natural ways to maintain and regain your health, no matter where in the world you live. Among your freedoms is the right to clean, unadulterated food free of genetic manipulation, pesticides, heavy metals or other contaminants and access to herbs, supplements, frequency devices and other means as therapies that may benefit or to protect your well-being without drugs and other dangerous interventions, if you choose.
For more information on our global programs, including the International Decade of Nutrition, and our US based ones, please visit us at www.HealthFreedomUSA.org and www.GlobalHealthFreedom.org and join the free email list for the Health Freedom eAlerts to keep you in the loop, informed and active defending your right to make your own decisions about your health and wellbeing!
Our activities are supported 100% by your tax deductible donations. Please give generously (http://www.healthfreedomusa.org/index.php?page_id=189) to the Natural Solutions Foundation. Thank you for your support.
Feel free to disseminate this information as widely as possible with full attribution.
Yours in health and freedom,
Dr. Rima
Rima E. Laibow, MD
Medical Director
Natural Solutions Foundation
www.HealthFreedomUSA.org
www.GlobalHealthFreedom.org
Given that flu vaccination (96% of all available doses contain high levels of mercury, the rest contain high-enough-levels to damage the recipient, too!) is being pushed for babies and children, the elderly and everyone in between and that the CDC recently stated that it misses the flu viruses causing this year’s seasonal flu at least 60% of the time, it is truly astonishing that the CDC is none the less pushing the annual vaccination of all children and seniors RIGHT NOW! QUICK, DON’T WAIT ANOTHER SECOND! with a vaccine which is dangerous, may be deadly, can shed the disease-causing viruses it contains to infect other, does the same with a large number of recipients and is medically worthless. Astonishing, that is, until you realize that the CDC never met a vaccine it did not love (including the deadly Rotovirus vaccine which, despite the fact that it it opens children to high incidences of seizures and pneumonia and, alas, death, is being approved non-the-less) and is willing to engage in deep cover-ups of vaccine injury to protect the industry it is supposed to be regulating. One has to conclude that the “Fact of Life” conflicts of interest in regulators that Ted Kennedy said were to be expected, not stringently routed out, when he proposed the lamentably successful “FDA Revitalization Act, S. 1810 in last year’s Congress are, in many cases, “Facts of Death” and “Facts of “Tragedy” and “Facts of Shame.
I am proposing the entire vaccine industry, without exception, for the Natural Solutions Foundation Hall of Shame. I am also proposing that the Administration and Staff of Arizona State University Join them. For Shame!
Read on. These are quotes taken from publicly available media about the proliferation of vaccination and the new “Marketing Partnerships” emerging to vaccinate everyone, even those for whom risk is rediculously low, except from the vaccine. Note that the strategy includes more adolescent vaccinations to encourage more adult vaccines, needed or not, deadly or not, dangerous or not.
For Shame!
Now get angry, and get everyone you know to join the Natural Solutions Foundation No-Forced-Vaccination Forum (http://tech.groups.yahoo.com/group/NSF-Panama/join) and get involved. NOW! The option is to NOT get involved and watch as you and everyone you know and love is vaccinated with God Knows What, over and over and over and over.
Now is the time to stop this horror story.
Yours in health and freedom,
Dr. Rima
Rima E. Laibow, MD
Medical Director
www.HealthFreedomUSA.org
www.GlobalHealthFreedom.org
Influenza Resource Center
Seasonal influenza epidemics are annually responsible for between 3 million and 5 million cases of severe illness and between 250,000 and 500,000 deaths worldwide. On average, approximately 36,000 deaths due to seasonal influenza occur in the United States each year. Influenza viruses can also cause pandemics, such as that of 1918 which killed at least 20 million people. Global health authorities are increasingly worried that the spread of highly pathogenic avian influenza in several areas of the world poses a serious, widespread threat to humans in the future, and the evolving situation is being closely monitored. Preparedness is the key to minimizing the effects of flu epidemics and pandemics, however. This collection of Medscape resources for clinicians provides essential information on influenza epidemiology, prevention, diagnosis, and management. For a comprehensive review, see the ACP Chapter, Respiratory Viral Infections.
http://www.medscape.com/resource/influenza?src=rcupdate#2
Medscape Infectious Diseases
Expert Column
Influenza Vaccination: Challenges for Adolescent and College Healthcare
Posted 01/15/2008
Allan L. Markus, MD, MS, MBA
Seasonal Influenza: Burden of Illness
According to the US Centers for Disease Control and Prevention, influenza and pneumonia combined were the eighth leading cause of death in the United States.[1] Furthermore, in a 1993 article by Sullivan and colleagues,[2] it was estimated that over 4.1 million people had excess respiratory illnesses due to influenza and that this translated to 16.6-17.9 million restricted activity work days. In a study by Molinari and colleagues,[3] they estimated that in 2003, the cost of caring for influenza in the United States alone would be $10.4 billion with another $16.3 billion in lost earnings and productivity — with a total economic cost of $87 billion.
Seasonal Influenza: Clinical Presentation
Typically patients become infected with influenza by inhalation of respiratory droplets from another infected individual. There is a 1- to 4-day incubation period, and once sick, the patient can be infectious up to 10 days after the onset of symptoms. Typical symptoms include significant malaise, fever, body aches, headache, sore throat, and cough. Unlike common cold symptoms, rhinorrhea and sinus congestion are not as prominent symptoms. Clinical symptoms alone cannot either rule in or rule out the presence of influenza, and rapid testing is now available for both influenza A and B. Secondary bacterial infections are possible, including staphylococcal pneumonia, usually heralded by a rapid worsening of the pulmonary picture and fevers in a patient with previously diagnosed influenza. The influenza virus may also cause a primary viral pneumonia. Most patients recover from influenza with little or no residual problems, although the malaise may last for 2-4 weeks in some cases.[4] [Emphasis mine -REL]
Seasonal Influenza: Vaccine and Treatment Rates
Although there are studies that show ranges of efficacy that can be up to 70% to 90% depending on the year for the inactivated influenza vaccine, the vaccination rate in the general population is low
(only 48% in 2004).[5] Despite medication being available for those who are diagnosed with the flu, it has been estimated that only 15% of primary care physicians prescribe this medication for those with the flu, and more importantly, 24% who met the criteria did not receive the medication.[6]
Seasonal Influenza: Implications of Vaccination of Low-Risk Populations
Adolescents and college-age students represent groups that are not at high risk for serious disease or mortality, [Emphasis mine - REL] but because of their living and going to school in such close quarters, they can easily spread the infection. Although there are segments of this population that are at higher risk for severe infections, such as those with asthma, HIV, and those who are pregnant, [in] the vast majority are healthy adults for whom there are little trial data to show clinical or economic benefit for mass influenza vaccination. Thus, with its low mortality in this younger population, making a case for universal vaccination of the adolescent and college-age population requires one to look beyond influenza’s mortality potential. [Emphasis mine - REL, comment: this requires one to lood beyond influenza' mortality potential to its profit potential -REL]
Healthy Adults
There are a few studies, however, that have looked at the impact of vaccination of healthy adults. In one of the only placebo-controlled, randomized trials of 2375 healthy adults, vaccination when well matched (efficacy over 80%) provided protection against influenza-like illness, excess physician visits, and lost workdays by 34%, 42%, and 32%, respectively.[7] This came at an overall cost of $11 per person vaccinated for the healthy adult. The Advisory Committee on Immunization Practices has recently put out its 2007 update of its 2006 recommendations and stated that all healthy people, including school-aged children, who want to reduce their risk of becoming ill with influenza should be vaccinated.[8] {Emphasis mine – REL]
College-Age Students
College-age students do not get vaccinated as often as those who are older. Some studies have shown that vaccination is linked to individual health beliefs on susceptibility to influenza and a higher degree of fear about side effects, but also may be related to costs.[9,10] In her August 2007 article, Middleman[10] proposed more use of mandatory vaccinations in adolescents to improve vaccination rates for other vaccines. She noted, however, the potential backlash for making certain vaccinations mandatory. This may be especially true in cases in which the benefit for certain populations in terms of economic outcomes has not been conclusively shown. [Emphasis mine, shame, hers - REL] Developing new models to get messages on susceptibility, safety, and costs to students on influenza vaccination could be an important method to increase the number of students choosing to become vaccinated. [Emphasis mine - risk, yours -REL]
http://www.medscape.com/viewarticle/568193
Seasonal Influenza: Novel Preparedness Approaches at Arizona State University
Arizona State University (ASU) is a 63,000-student university located in the greater Phoenix metropolitan area. Its largest campus is the Tempe campus, having 55,000 students who attend classes and with about 9000 living on campus. The Campus Health Service provides the primary healthcare services on the 55,000-student Tempe Campus and collaborates with its healthcare partners at the 3 other campus locations. ASH decided to partner with both a vaccine manufacturer (CSL Biotherapies) and an advertising agency (Hal Lewis Group) to improve messaging and increase the vaccination numbers on our campus.
Methods [Emphasis mine -REL]
ASU was approached by CSL Biotherapies* with the concept of developing a more comprehensive program to distribute vaccine to students, faculty, and staff. [Emphasis mine- REL] We used a marketing theme called “Season Pass.” The strategy for increasing vaccination rates was multifaceted:
* Influenza vaccine distribution events: Campus Health Service held 2 week-long events at the Student Union. Timing was done during the peak period of student activity from 10:00 am to 2:00 pm.
* Giveaway strategy: All students who received a vaccine received an ASU T-shirt that displayed the Season Pass logo and passed on the message to make the campus “Flu-less.” Students also received a postage-paid postcard that they could send home to inform parents that they had received their flu shot.
* Residence hall distribution: Nursing staff planned days to administer vaccine in the residential halls.
* Campus signage and advertising campaign: ASU, in association with a professional branding and marketing team, developed signage and media advertising that included student newspapers and radio stations marketing the Season Pass campaign.
Results
In the 2006-2007 season, ASU ran a number of employee flu clinics and distributed vaccine through our health center and the Student Union to students. Nine hundred twenty-seven vaccines were distributed to students, and 1416 were distributed to employees for a total of 2343 doses of vaccination.
During the fall 2007 season, using the new methodology above, 2049 students were vaccinated and 1931 employees were vaccinated, for a total of 3980 vaccinations distributed (Figure). These results occurred despite an increase in price from $10/vaccination in 2006 to $18/vaccination for students and $20/vaccination for employees in 2007.
http://www.medscape.com/viewarticle/568193_2
*CSL Biotherapies is a subsidiary of CSL Limited, which operates one of the world’s largest flu vaccine manufacturing facilities for supply to global markets … http://www.cslbiotherapies-us.com/s1/cs/becs/1160756085082/content/1160756085001/home.htm
